- ICH GCP
- US Clinical Trials Registry
- Clinical Trial NCT04957771
Effect of Standardized Exercise on Cardiopulmonary Function in Patients With Permanent Pacemaker Implantation
July 4, 2021 updated by: Peking University Third Hospital
The purpose of this study is to observe the changes of cardiopulmonary endurance in patients with pacemaker implantation after long-term exercise, to explore the significance of exercise on patients with pacemaker implantation, and to analyze the difference of the effect of exercise on cardiopulmonary endurance in patients with normal LVEF of different pacing ratios
Study Overview
Status
Completed
Conditions
Intervention / Treatment
Study Type
Interventional
Enrollment (Actual)
64
Phase
- Not Applicable
Contacts and Locations
This section provides the contact details for those conducting the study, and information on where this study is being conducted.
Study Locations
-
-
Haidian
-
Beijing, Haidian, China, 100191
- Peking University Third Hospital
-
-
Participation Criteria
Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.
Eligibility Criteria
Ages Eligible for Study
18 years to 75 years (Adult, Older Adult)
Accepts Healthy Volunteers
No
Genders Eligible for Study
All
Description
Inclusion Criteria:
- 18-75 years old patients with pacemaker implantation for the first time,
- 3-6 months after operation
- stable condition,
- independent walking ability.
Exclusion Criteria:
- Cognitive impairment;
- ICD, CRT / Crtd implanted,
- patients with neurogenic syncope;
- Atrial tachycardia, atrial fibrillation,
- NYHA class II or above,
- difficult to control hypertension;
- Musculoskeletal disease limiting activity
- nervous system disease,
- severe respiratory disease,
- Patients with acute inflammation,
- cancer and other diseases uncontrolled.
Study Plan
This section provides details of the study plan, including how the study is designed and what the study is measuring.
How is the study designed?
Design Details
- Primary Purpose: Prevention
- Allocation: Randomized
- Interventional Model: Parallel Assignment
- Masking: None (Open Label)
Arms and Interventions
Participant Group / Arm |
Intervention / Treatment |
|---|---|
|
Experimental: Regular exercise group
|
Aerobic exercise, evaluated by cardiopulmonary exercise test, 3-5 times a week
|
|
No Intervention: non-regurlar exercise group
|
What is the study measuring?
Primary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
|---|---|---|
|
Parameters related to exercise cardiopulmonary assessment
Time Frame: followed up for one year
|
VO2peak
|
followed up for one year
|
Collaborators and Investigators
This is where you will find people and organizations involved with this study.
Sponsor
Investigators
- Principal Investigator: lijie sun, MD, Peking University Third Hospital
Study record dates
These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.
Study Major Dates
Study Start (Actual)
August 1, 2019
Primary Completion (Actual)
July 31, 2020
Study Completion (Actual)
July 31, 2020
Study Registration Dates
First Submitted
June 27, 2021
First Submitted That Met QC Criteria
July 4, 2021
First Posted (Actual)
July 12, 2021
Study Record Updates
Last Update Posted (Actual)
July 12, 2021
Last Update Submitted That Met QC Criteria
July 4, 2021
Last Verified
August 1, 2019
More Information
Terms related to this study
Other Study ID Numbers
- LM2019185
Plan for Individual participant data (IPD)
Plan to Share Individual Participant Data (IPD)?
Undecided
Drug and device information, study documents
Studies a U.S. FDA-regulated drug product
No
Studies a U.S. FDA-regulated device product
No
product manufactured in and exported from the U.S.
No
This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.
Clinical Trials on Pacemaker DDD
-
Alexandria UniversityRecruiting
-
Adela DrozdovaNot yet recruiting
-
Biotronik SE & Co. KGCompleted
-
National University Hospital, SingaporeActive, not recruiting
-
Nantes University HospitalMinistry of Health, FranceUnknown
-
Region GävleborgUnknown
-
Assiut UniversityNot yet recruiting
-
RWTH Aachen UniversityCompleted
-
Edward HospitalCompleted
-
Beth Israel Deaconess Medical CenterPatient-Centered Outcomes Research InstituteRecruitingPacemaker DDD | Implantable Defibrillator UserUnited States
Clinical Trials on Supervise and guide regular exercise
-
University of ValenciaCompleted
-
Universidad Católica San Antonio de MurciaActive, not recruitingPlyometric ExercisesSpain
-
China National Center for Cardiovascular DiseasesNot yet recruitingCardiac Rehabilitation | Vascular Health | M-health | Mind-body Exercise
-
University of ThessalyRecruiting
-
Peking University People's HospitalNot yet recruiting
-
Ege UniversityCompletedMultiple Sclerosis | Neuro-Degenerative Disease | Exercise InterventionTurkey
-
Princess Nourah Bint Abdulrahman UniversityNamik Kemal UniversityCompleted
-
Orla DeeganUniversity College Dublin; Mater Misericordiae University HospitalCompleted
-
Children's Hospital of Fudan UniversityShanghai Municipal Science and Technology CommissionCompletedAttention Deficit Hyperactivity DisorderChina
-
St. Olavs HospitalUllevaal University Hospital; Asker & Baerum Hospital; Haukeland University Hospital and other collaboratorsActive, not recruiting